Catalyst

Slingshot members are tracking this event:

Reata's (RETA) bardoxolone in chronic kidney disease caused by Alport syndrome data will be presented at The World Congress of Nephrology 2021 April 15 – 19, 2021

Source Link:
https://www.reatapharma.com/press-releases/reata-pharmaceuticals-announces-presentations-at-upcoming-medical-conferences/?releaseyear=2021

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RETA Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 15, 2021
Occurred Source:
https://www.reatapharma.com/investors/events-and-presentations/event-details/2021/2021-WCN-Poster/default.aspx
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Bardoxolone, Alport Syndrome
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.